Macular Edema following cataract surgery in Diabetic type 2 patients

Completed

• Conditions: diabetic macular edema; 10047060; 10018424

• Registration Number: NL-OMON33232
• Lead Sponsor: Oogziekenhuis Rotterdam

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Last Update Posted: 6 May 2024

Recruitment & Eligibility

• Status: Completed
• Sex: Not specified
• Target Recruitment: 170

Inclusion Criteria

- Informed consent
- Cataract
- Diabetes Mellitus type 2
- Mild to moderate non-proliferative diabetic retinopathy

Exclusion Criteria

- Severity of cataract obstructing ophthalmic inspection (i.e. NO5, NC5, NO6, NC6, C5, P5) and/or (sufficiently accurate) OCT measurements (i.e. a Signal Strength Index < 35).
- Any other corneal, media, retinal or optic nerve disorder, except stage I dry ARMD
- Clinically significant macular edema
- Pregnant, no active birth control
- Use of Diamox
- Use of Avandia (rosiglitazone)
- Use of oral steroids
- Use of Coumarin derivatives and heparin derivatives
- Status after ablatio retina/vitrectomy
- History of steroid response

Study & Design

• Study Type: Interventional
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
<p>Incidence DME, BCVA, foveal thickness. </p><br>

Secondary Outcome Measures

Name	Time	Method
<p>IOP.</p><br>